Logo image of CLI

MACK-CALI REALTY CORP (CLI) Stock Fundamental Analysis

NYSE:CLI - New York Stock Exchange, Inc. - REIT

18.35  -0.04 (-0.22%)

After market: 18.35 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CLI. CLI was compared to 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of CLI have multiple concerns. CLI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CLI had negative earnings in the past year.
CLI Yearly Net Income VS EBIT VS OCF VS FCFCLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 -200M -400M -600M -800M -1B

1.2 Ratios

Industry RankSector Rank
ROA -0.6%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLI Yearly ROA, ROE, ROICCLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 5 -5

1.3 Margins

Industry RankSector Rank
OM 1.69%
PM (TTM) -8.44%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLI Yearly Profit, Operating, Gross MarginsCLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for CLI remains at a similar level compared to 1 year ago.
Compared to 1 year ago, CLI has a worse debt to assets ratio.
CLI Yearly Shares OutstandingCLI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M
CLI Yearly Total Debt VS Total AssetsCLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 1B 2B 3B 4B 5B

2.2 Solvency

CLI has a Debt/Equity ratio of 1.82. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CLI Yearly LT Debt VS Equity VS FCFCLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 1B -1B 2B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.65% over the past year.
The Revenue has decreased by -1.41% in the past year.
Measured over the past years, CLI shows a very negative growth in Revenue. The Revenue has been decreasing by -12.02% on average per year.
EPS 1Y (TTM)81.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-450%
Revenue 1Y (TTM)-1.41%
Revenue growth 3Y-11.92%
Revenue growth 5Y-12.02%
Sales Q2Q%7.78%

3.2 Future

The Earnings Per Share is expected to grow by 0.95% on average over the next years.
The Revenue is expected to grow by 4.79% on average over the next years.
EPS Next Y-65.7%
EPS Next 2Y7.87%
EPS Next 3Y16.13%
EPS Next 5Y0.95%
Revenue Next Year-3.9%
Revenue Next 2Y-1.99%
Revenue Next 3Y3.38%
Revenue Next 5Y4.79%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLI Yearly Revenue VS EstimatesCLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
CLI Yearly EPS VS EstimatesCLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CLI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLI Price Earnings VS Forward Price EarningsCLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.15
CLI Per share dataCLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as CLI's earnings are expected to grow with 16.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.87%
EPS Next 3Y16.13%

More info and screens

3

5. Dividend

5.1 Amount

CLI has a Yearly Dividend Yield of 3.24%.
Compared to an average S&P500 Dividend Yield of 2.36, CLI pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.24%

5.2 History

The dividend of CLI decreases each year by -5.01%.
CLI has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-5.01%
Div Incr YearsN/A
Div Non Decr YearsN/A
CLI Yearly Dividends per shareCLI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 0.2 0.4 0.6

5.3 Sustainability

69.62% of the earnings are spent on dividend by CLI. This is not a sustainable payout ratio.
DP69.62%
EPS Next 2Y7.87%
EPS Next 3Y16.13%
CLI Yearly Income VS Free CF VS DividendCLI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 0 -200M -400M -600M -800M -1B
CLI Dividend Payout.CLI Dividend Payout, showing the Payout Ratio.CLI Dividend Payout.PayoutRetained Earnings

More info and screens

MACK-CALI REALTY CORP

NYSE:CLI (12/9/2021, 8:16:41 PM)

After market: 18.35 0 (0%)

18.35

-0.04 (-0.22%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners93.33%
Inst Owner Change4.53%
Ins Owners2.19%
Ins Owner Change0%
Market Cap1.67B
Analysts51.43
Price Target19.72 (7.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.24%
Yearly Dividend0.6
Dividend Growth(5Y)-5.01%
DP69.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.18
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB N/A
EV/EBITDA 34.15
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.54
BVpS14.38
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.69%
PM (TTM) -8.44%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-450%
EPS Next Y-65.7%
EPS Next 2Y7.87%
EPS Next 3Y16.13%
EPS Next 5Y0.95%
Revenue 1Y (TTM)-1.41%
Revenue growth 3Y-11.92%
Revenue growth 5Y-12.02%
Sales Q2Q%7.78%
Revenue Next Year-3.9%
Revenue Next 2Y-1.99%
Revenue Next 3Y3.38%
Revenue Next 5Y4.79%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A